Statera Biopharma, Inc. Shareholders' Equity
Statera Biopharma, Inc. had Shareholders' Equity of -$10.24 million as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2022-11-14
- 2022-09-30: Stockholders' Equity Attributable to Parent -$10.24M.
- 2022-06-30: Stockholders' Equity Attributable to Parent -$6.99M.
- 2022-03-31: Stockholders' Equity Attributable to Parent -$2.49M.
- 2021-12-31: Stockholders' Equity Attributable to Parent -$1.57M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2022-09-30 | -$10.24M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$6.99M 10-Q · filed 2022-10-28 | |
| 2022-03-31 | -$2.49M 10-Q · filed 2022-10-21 | |
| 2021-12-31 | -$1.57M 10-Q · filed 2022-11-14 | |
| 2021-09-30 | $74.12M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $8.57M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $9.22M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | -$2.96M 10-Q · filed 2021-08-16 | |
| 2020-12-30 | -$3.66M 10-Q · filed 2021-11-15 | |
| 2020-09-30 | -$2.22M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | -$1.71M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | -$4.21M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | -$4.06M 10-K · filed 2021-03-22 | -$4.52M 10-K · filed 2020-04-15 |
| 2019-09-30 | -$3.36M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | -$2.91M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | -$2.30M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | -$1.45M 10-K · filed 2020-04-15 | |
| 2018-09-30 | -$997.59K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $130.66K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $1.04M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $2.20M 10-K · filed 2019-03-07 | |
| 2017-09-30 | $3.36M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $4.61M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $5.93M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $7.52M 10-K · filed 2018-03-06 | |
| 2016-09-30 | $8.91M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $7.77M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $9.77M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $9.89M 10-K · filed 2017-02-22 | |
| 2015-09-30 | $10.63M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | -$9.97M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | -$5.46M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | -$1.61M 10-K · filed 2016-02-23 | |
| 2014-09-30 | -$10.35M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | -$6.39M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | -$6.70M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | -$9.52M 10-K · filed 2015-02-27 | |
| 2013-09-30 | -$9.27M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | -$5.80M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | -$3.13M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $6.33M 10-K · filed 2014-03-17 | |
| 2012-09-30 | -$8.86M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $1.21M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $4.95M 10-Q · filed 2012-05-07 | |
| 2011-12-31 | $9.06M 10-K · filed 2013-03-18 | |
| 2011-09-30 | $15.48M 10-Q/A · filed 2011-11-14 | |
| 2011-06-30 | $17.45M 10-Q · filed 2011-08-09 | |
| 2010-12-31 | -$15.70M 10-K · filed 2012-03-13 |